Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
164.49
+2.16 (1.33%)
At close: Mar 9, 2026, 4:00 PM EDT
164.63
+0.14 (0.09%)
After-hours: Mar 9, 2026, 7:19 PM EDT

Axsome Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
8,4149,2074,1003,7663,3491,424
Upgrade
Market Cap Growth
33.65%124.55%8.88%12.44%135.22%-53.20%
Upgrade
Enterprise Value
8,3099,1013,9653,5353,2161,359
Upgrade
Last Close Price
164.49182.6484.6179.5977.1337.78
Upgrade
PS Ratio
13.1814.4210.6313.9266.94-
Upgrade
PB Ratio
94.79104.2871.9219.7230.5791.10
Upgrade
P/TBV Ratio
235.47257.66-29.9784.6191.10
Upgrade
EV/Sales Ratio
13.0114.2510.2813.0664.28-
Upgrade
Debt / Equity Ratio
2.472.473.380.980.863.18
Upgrade
Net Debt / Equity Ratio
-1.19-1.19-2.15-1.05-0.97-2.35
Upgrade
Net Debt / EBITDA Ratio
0.650.650.501.140.620.30
Upgrade
Net Debt / FCF Ratio
1.121.120.951.370.910.34
Upgrade
Asset Turnover
1.011.010.670.590.24-
Upgrade
Inventory Turnover
2.172.172.162.68--
Upgrade
Quick Ratio
1.451.451.993.462.473.75
Upgrade
Current Ratio
1.561.562.113.632.543.75
Upgrade
Return on Equity (ROE)
-252.12%-252.12%-231.63%-159.21%-298.97%-201.51%
Upgrade
Return on Assets (ROA)
-16.81%-16.81%-27.28%-24.86%-52.30%-56.91%
Upgrade
Return on Capital Employed (ROCE)
-54.40%-54.40%-74.60%-40.70%-74.70%-192.70%
Upgrade
Earnings Yield
-2.18%-1.99%-7.00%-6.35%-5.59%-9.16%
Upgrade
FCF Yield
-1.12%-1.02%-3.14%-3.87%-3.50%-7.62%
Upgrade
Buyback Yield / Dilution
-3.82%-3.82%-5.48%-11.73%-8.07%-1.11%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.